Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2019. Go to the latest filing (Q3 2026)

11.5B USDQ1 2019
Total value of stock positions
11.5B USD
Positions
33
Share of the ten largest
66.9%

The ten largest positions Q1 2019

  1. eBay Inc. 9.4%▲ +39.5%
  2. Viasat Inc 9.2%unchanged
  3. Fox Corporation (Class A) 8.7%new
  4. Liberty Global PLC 8.2%▲ +31.4%
  5. Cheniere Energy Inc 7.5%▼ −11.1%
  6. Qorvo Inc 6.6%▼ −0.9%
  7. Allergan PLC 6.0%▲ +0.3%
  8. Synchrony Financial 3.9%▼ −2.0%
  9. PG&E Corporation 3.8%▲ +58.3%
  10. Cbs Corp New 3.5%▲ +235.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2019

Positions Q1 2019 per 13F filing, 33 of 33
Symbol Weight Shares Reported value Change Held since
EBAY eBay Inc. 9.4% 29,286,000 1.1B USD +39.5% increased Q4 2018 2 quarters
Viasat Inc 9.2% 13,732,068 1.1B USD unchanged Q2 2013 or earlier 24 quarters
FOXA Fox Corporation (Class A) 8.7% 27,322,720 1.0B USD new Q1 2019 1 quarter
Liberty Global PLC 8.2% 39,092,995 946.4M USD +31.4% increased Q3 2018 3 quarters
Cheniere Energy Inc 7.5% 12,618,308 862.6M USD −11.1% reduced Q1 2014 21 quarters
Qorvo Inc 6.6% 10,589,082 759.6M USD −0.9% reduced Q1 2017 9 quarters
Allergan PLC 6.0% 4,769,695 698.3M USD +0.3% increased Q1 2016 13 quarters
SYF Synchrony Financial 3.9% 14,260,557 454.9M USD −2.0% reduced Q3 2016 11 quarters
PCG PG&E Corporation 3.8% 24,500,000 436.1M USD +58.3% increased Q1 2018 5 quarters
Cbs Corp New 3.5% 8,542,016 406.0M USD +235.4% increased Q4 2018 2 quarters
Celgene Corp 3.3% 4,000,000 377.4M USD new Q1 2019 1 quarter
MCK McKesson Corporation 2.9% 2,815,011 329.5M USD +63.7% increased Q3 2017 7 quarters
Pioneer Nat Res Co 2.6% 2,001,814 304.8M USD −55.5% reduced Q3 2017 7 quarters
Colony Cap Inc New 2.3% 49,687,370 264.3M USD unchanged Q2 2018 4 quarters
Atara Biotherapeutics Inc 2.2% 6,380,519 253.6M USD +2.0% increased Q4 2014 18 quarters
Antero Res Corp 2.2% 28,587,791 252.4M USD unchanged Q3 2014 19 quarters
Takeda Pharmaceutical Co Ltd 1.9% 10,669,021 217.3M USD new Q1 2019 1 quarter
Theravance Biopharma Inc 1.8% 9,309,168 211.0M USD unchanged Q2 2014 20 quarters
Univar Inc 1.8% 9,500,000 210.5M USD unchanged Q3 2018 3 quarters
FOX Fox Corporation (Class B) 1.8% 5,680,307 203.8M USD new Q1 2019 1 quarter
Akebia Therapeutics Inc 1.7% 24,471,453 200.4M USD unchanged Q4 2018 2 quarters
COR Cencora 1.7% 2,404,299 191.2M USD +19.4% increased Q3 2017 7 quarters
BMY Bristol Myers Squibb 1.7% 4,000,000 190.8M USD new Q1 2019 1 quarter
Liberty Global PLC 1.1% 4,957,205 123.5M USD unchanged Q3 2018 3 quarters
Sinclair Broadcast Group Inc 1.0% 2,908,096 111.9M USD −3.1% reduced Q2 2018 4 quarters
Nexstar Media Group Inc 0.9% 1,000,000 108.4M USD +5.3% increased Q4 2018 2 quarters
Veritiv Corp 0.8% 3,564,439 93.8M USD unchanged Q3 2014 19 quarters
Translate Bio Inc 0.6% 6,491,298 63.9M USD 0.0% increased Q2 2018 4 quarters
DIS Walt Disney Company (The) 0.4% 399,151 44.3M USD new Q1 2019 1 quarter
Trilogy Metals Inc New 0.3% 13,050,758 32.0M USD unchanged Q3 2016 11 quarters
Gossamer Bio Inc 0.2% 1,267,171 26.1M USD new Q1 2019 1 quarter
Paratek Pharmaceuticals Inc 0.1% 2,394,498 12.8M USD unchanged Q4 2014 18 quarters
Gty Technology Holdings Inc < 0.1% 1,466,666 884.0K USD new Q1 2019 1 quarter

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 2 positions in convertible bonds and bonds worth 357.5M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Tesla Inc principal 300.0M USD 328.3M USD
  • Theravance Biopharma Inc principal 30.0M USD 29.2M USD

Breakdown by sector

  • Communication Services 10.8%
  • Consumer Discretionary 9.4%
  • Health Care 6.2%
  • Financials 3.9%
  • Utilities 3.8%
  • not in our coverage 65.9%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close